Home › Funds › Illumine Investment Management, LLC › NBIX
Illumine Investment Management, LLC position in NBIX
NEUROCRINE BIOSCIENCES INC · Health Care
Illumine Investment Management, LLC reported holding 9,632 shares of NBIX (NEUROCRINE BIOSCIENCES INC) in its Q1 2026 13F filing — a position valued at US$1.3M, representing 0.98% of its reported portfolio and ranking #41 among its reported holdings. Illumine Investment Management, LLC has disclosed NBIX holdings in 6 of the last 6 reported quarters, going back to Q4 2024.
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
How Illumine Investment Management, LLC's NBIX position evolved
Illumine Investment Management, LLC first disclosed a stake in NBIX in Q4 2024 at 9,502 shares (US$1.3M). The position peaked in Q4 2025 at 9,656 shares, worth US$1.4M. Across 6 filings, Illumine Investment Management, LLC increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q1 2026) shows 9,632 shares valued at US$1.3M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 9.50K | $1.30M | New |
| Q1 2025 | 9.64K | $1.07M | Add |
| Q2 2025 | 9.88K | $1.24M | Add |
| Q3 2025 | 9.74K | $1.37M | Reduce |
| Q4 2025 | 9.66K | $1.37M | Reduce |
| Q1 2026 | 9.63K | $1.27M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NBIX and 13F data
NBIX (NEUROCRINE BIOSCIENCES INC) is a Health Care company. 34 other funds we track also report a position in NBIX — the largest reported positions include Renaissance Technologies (US$393.7M), Two Sigma Investments (US$349.9M), Vestal Point Capital, LP (US$316.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NBIX
- Renaissance Technologies 2.34M sh · $393.68M · Q2 2026
- Two Sigma Investments 2.08M sh · $349.92M · Q2 2026
- Vestal Point Capital, LP 1.88M sh · $316.85M · Q2 2026
- RTW INVESTMENTS, LP 1.27M sh · $213.69M · Q2 2026
- IEQ CAPITAL, LLC 640.30K sh · $107.91M · Q2 2026
More on Illumine Investment Management, LLC
FAQ
How long has Illumine Investment Management, LLC held NBIX?
Illumine Investment Management, LLC has disclosed NBIX holdings in 6 of the last 6 reported quarters, going back to Q4 2024.
What is Illumine Investment Management, LLC's current position in NBIX?
As of Q1 2026, Illumine Investment Management, LLC holds 9.63K shares of NBIX (NEUROCRINE BIOSCIENCES INC), valued at $1.27M, representing 0.98% of its reported portfolio and ranking #41.
Has Illumine Investment Management, LLC been buying or selling NBIX?
In the latest 13F filing (Q1 2026), Illumine Investment Management, LLC held unchanged its position in NBIX. The position peaked in Q4 2025 at 9.66K shares.
Which other funds hold NBIX?
Other major institutional holders of NBIX include Renaissance Technologies, Two Sigma Investments, Vestal Point Capital, LP, among 34 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.